| 1 (85) | MedImmune, LLC. | USA |  |
| 2 (120) | Regeneron Pharmaceuticals Inc | USA | |
| 3 (126) | Hoffmann-La Roche, GmbH., Germany | DEU | |
| 4 (127) | IBM United States | USA | |
| 5 (128) | Hoffmann-La Roche Ltd, United States | USA | |
| 6 (134) | Novartis Institutes for Biomedical Research, Switzerland | CHE | |
| 7 (140) | Novartis Institutes for Biomedical Research, United States | USA | |
| 8 (141) | Genentech Inc | USA | |
| 9 (161) | Bristol-Myers Squibb Company, United States | USA | |
| 10 (187) | Biogen Idec, USA | USA | |
| 11 (207) | Sanofi, United States | USA | |
| 12 (219) | Merck & Co Inc, United States | USA | |
| 13 (220) | GlaxoSmithKline, United States | USA | |
| 14 (221) | AstraZeneca, United Kingdom | GBR | |
| 15 (233) | Siemens AG, Germany | DEU | |
| 16 (239) | Pfizer Inc, United States | USA | |
| 17 (246) | Gilead Sciences Inc, United States | USA | |
| 18 (254) | BMJ Group | GBR | |
| 19 (260) | Hoffmann-La Roche Ltd, Switzerland | CHE | |
| 20 (268) | Janssen Biotech Inc | USA | |
| 21 (273) | Amgen, USA | USA | |
| 22 (283) | Merck KGaA, Germany | DEU | |
| 23 (286) | Eli Lilly and Company, United States | USA | |
| 24 (292) | AstraZeneca, United States | USA | |
| 25 (309) | GlaxoSmithKline, United Kingdom | GBR | |
| 26 (312) | Novo Nordisk A/S | DNK | |
| 27 (321) | Janssen Research & Development, LLC | BEL | |
| 28 (325) | Boehringer Ingelheim, USA | USA | |
| 29 (332) | Boehringer Ingelheim GmbH Germany | DEU | |
| 30 (333) | Celgene Corp | USA | |
| 31 (336) | Siemens AG, USA | USA | |
| 32 (338) | Bayer AG, Germany | DEU | |
| 33 (364) | AbbVie Inc, United States | USA | |
| 34 (382) | Takeda Pharmaceuticals International Inc, USA | USA | |
| 35 (392) | Philips Research, Eindhoven | NLD | |
| 36 (406) | Novartis, Switzerland | CHE | |
| 36 (406) | VTT Technical Research Centre of Finland | FIN | |
| 38 (427) | Daiichi Sankyo Co., Ltd. Japan | JPN | |
| 39 (441) | AstraZeneca, Sweden | SWE | |
| 40 (442) | GlaxoSmithKline, Belgium | BEL | |
| 41 (443) | Shionogi & Co Ltd | JPN | |
| 42 (451) | Danone Nederland BV | NLD | |
| 43 (456) | BASF, Germany | DEU | |
| 44 (457) | Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique | FRA | |
| 45 (458) | Siemens Healthineers, USA | USA | |
| 46 (465) | Novartis Pharmaceuticals, United States | USA | |
| 47 (472) | Takeda Pharmaceutical Co Inc, Japan | JPN | |
| 48 (494) | Nestle Switzerland | CHE | |
| 49 (500) | Translational Research Institute | AUS | |
| 50 (501) | Bayer Corp, USA | USA | |
| 51 (520) | Pfizer Inc, United Kingdom | GBR | |
| 52 (531) | UCB Pharma SA, Brussels | BEL | |
| 53 (539) | Lockheed Martin Corp * | USA | |
| 54 (555) | SINTEF Group | NOR | |
| 55 (557) | Astellas Pharma Inc | JPN | |
| 56 (560) | GeneDx | USA | |
| 57 (572) | Allergan plc, USA | USA | |
| 58 (597) | Eli Lilly and Company Ltd., United Kingdom | GBR | |
| 59 (606) | Springer Nature, New Zealand | NZL | |
| 60 (618) | RTI Health Solutions | USA | |
| 61 (620) | Johnson & Johnson, United States | USA | |
| 62 (630) | IMEC International | BEL | |
| 63 (656) | EMMES Corp | USA | |
| 64 (658) | Nippon Telegraph and Telephone Corp, Japan | JPN | |
| 65 (701) | Elsevier, France | FRA | |
| 66 (723) | ARUP Laboratories | USA | |
| 67 (736) | Pharmaceutical Product Development LLC | USA | |
|
